These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18806771)

  • 21. Atherosclerosis imaging in statin intervention trials.
    Yanai H; Yoshida H; Tomono Y; Tada N
    QJM; 2007 May; 100(5):253-62. PubMed ID: 17456609
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-inflammatory mechanism of statins in atherosclerosis management].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2818-20. PubMed ID: 16324336
    [No Abstract]   [Full Text] [Related]  

  • 24. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
    Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitavastatin prevents intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia.
    Nakagawa H; Tsunooka N; Yamamoto Y; Yoshida M; Nakata T; Kawachi K
    Surgery; 2009 May; 145(5):542-9. PubMed ID: 19375614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive medical therapy can reverse atherosclerosis. Research shows that lifestyle changes and medications can help remove dangerous plaque from your arteries.
    Heart Advis; 2008 Sep; 11(9):4-5. PubMed ID: 19219944
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical management of atheromatous renovascular disease.
    Kalra PA
    Clin Med (Lond); 2009 Jun; 9(3):264-8. PubMed ID: 19634395
    [No Abstract]   [Full Text] [Related]  

  • 29. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On call. I am 55 years old. My cholesterol counts are normal, but my wife clipped a newspaper article about a study that found statin drugs prevent heart attacks even in people with normal cholesterol. My golfing partners all take cholesterol medication-- should I join them?
    Simon HB
    Harv Mens Health Watch; 2009 Mar; 13(8):8. PubMed ID: 19378478
    [No Abstract]   [Full Text] [Related]  

  • 32. eComment: Statins decelerate the sclerosis progression of senile aortic valves in only selected cases.
    Apostolakis E; Koniari I
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):689. PubMed ID: 18664673
    [No Abstract]   [Full Text] [Related]  

  • 33. Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Holdaas H
    Eur Heart J; 2008 Feb; 29(4):425-6. PubMed ID: 18276612
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 37. [Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease].
    Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):275-7. PubMed ID: 21600141
    [No Abstract]   [Full Text] [Related]  

  • 38. Does hypercholesterolemia improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery?
    Mascitelli L; Pezzetta F; Goldstein MR
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):256; author reply 256-7. PubMed ID: 19577102
    [No Abstract]   [Full Text] [Related]  

  • 39. From PK/PD to QSP: Understanding the Dynamic Effect of Cholesterol-Lowering Drugs on Atherosclerosis Progression and Stratified Medicine.
    Pichardo-Almarza C; Diaz-Zuccarini V
    Curr Pharm Des; 2016; 22(46):6903-6910. PubMed ID: 27592718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.